These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15049586)

  • 41. Hypercalcemia and calcium oxalate urolithiasis in cats: a report of five cases.
    McClain HM; Barsanti JA; Bartges JW
    J Am Anim Hosp Assoc; 1999; 35(4):297-301. PubMed ID: 10416773
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Medical evaluation and treatment of urolithiasis.
    Nicoletta JA; Lande MB
    Pediatr Clin North Am; 2006 Jun; 53(3):479-91, vii. PubMed ID: 16716792
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rational evaluation of urinary stone disease.
    Hesse A; Straub M
    Urol Res; 2006 Apr; 34(2):126-30. PubMed ID: 16450128
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Urinary metabolic evaluations in normal and stone forming children.
    DeFoor W; Asplin J; Jackson E; Jackson C; Reddy P; Sheldon C; Erhard M; Minevich E
    J Urol; 2006 Oct; 176(4 Pt 2):1793-6. PubMed ID: 16945651
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolic evaluation of urolithiasis patients from eastern Croatia.
    Babić-Ivancić V; Avdagić SC; Serić V; Kontrec J; Tucak A; Füredi-Milhofer H; Marković M
    Coll Antropol; 2004 Dec; 28(2):655-66. PubMed ID: 15666597
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epitaxial deposition of calcium oxalate on uric acid rich stone matrix is induced by a 29 kDa protein.
    Srinivasan S; Kalaiselvi P; Varalakshmi P
    Clin Chim Acta; 2006 Feb; 364(1-2):267-74. PubMed ID: 16139257
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A critical analysis of the role of gut Oxalobacter formigenes in oxalate stone disease.
    Siva S; Barrack ER; Reddy GP; Thamilselvan V; Thamilselvan S; Menon M; Bhandari M
    BJU Int; 2009 Jan; 103(1):18-21. PubMed ID: 19021605
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk formulas in calcium oxalate urolithiasis.
    Tiselius HG
    World J Urol; 1997; 15(3):176-85. PubMed ID: 9228725
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Diagnostic and therapeutic approach in patients with urinary calculi].
    ; Croppi E; Cupisti A; Lombardi M; Marangella M; Sanseverino R; Carrano F; Croppi E; Cupisti A; D'Addessi A; Drudi FM; Gambaro G; Lombardi M; Micali S; Simeoni PG; Tasca A; Terribile M; Zattoni F; Baggio B; Bianchi G; Caudarella R; Cicerello E; Cosciani-Cunico S; D'angelo AR; Marangella M; Mossetti G; Muto G; Novenne A; Prampolini M; Sanseverino R; Strazzullo P; Trinchieri A; Vezzoli G
    G Ital Nefrol; 2010; 27(3):282-9. PubMed ID: 20540021
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [24-hour urinary oxalate excretion in healthy children and in children with calcium urolithiasis].
    Sikora P; Bieniaś B; Wawrzyszuk M; Zajaczkowska M
    Pol Merkur Lekarski; 2008; 24 Suppl 4():76-9. PubMed ID: 18924510
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanism underlying the low prevalence of pediatric calcium oxalate urolithiasis.
    Momohara C; Tsujihata M; Yoshioka I; Tsujimura A; Nonomura N; Okuyama A
    J Urol; 2009 Sep; 182(3):1201-9. PubMed ID: 19625038
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of calcium supplements on the risk of renal stone formation in a population with low oxalate intake.
    Stitchantrakul W; Sopassathit W; Prapaipanich S; Domrongkitchaiporn S
    Southeast Asian J Trop Med Public Health; 2004 Dec; 35(4):1028-33. PubMed ID: 15916110
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Urolithiasis in chronic renal failure with hemodialysis].
    Nutahara K; Oshi M; Higashihara E
    Nihon Rinsho; 1992 Jan; 50 Suppl():855-60. PubMed ID: 1578778
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical experience with pediatric urolithiasis.
    Noe HN; Stapleton FB; Jerkins GR; Roy S
    J Urol; 1983 Jun; 129(6):1166-8. PubMed ID: 6854792
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [A metabolic approach to patients with calculi].
    Wildschutz T; Ekane S; Simon J; Schulman CC
    Acta Urol Belg; 1997 Oct; 65(3):9-14. PubMed ID: 9471888
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Obstructive urolithiasis in a female lamb].
    Kaufmann C; Sicher D; Indermaur B; Fluri E
    Schweiz Arch Tierheilkd; 1999; 141(10):469-73. PubMed ID: 10549225
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Progress in urolithiasis research. Report and comments on the Urolithiasis Symposium 1981, Bonn (author's transl)].
    Asper R
    Urol Int; 1981; 36(6):346-52. PubMed ID: 7324300
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Etiology and pathogenesis of urolithiasis].
    Kmiecik J; Kucharska E; Sułowicz W; Ochmański W
    Przegl Lek; 1997; 54(3):173-9. PubMed ID: 9297194
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rendering stone fragments paramagnetic with iron-oxide microparticles improves the efficiency and effectiveness of endoscopic stone fragment retrieval.
    Tracy CR; McLeroy SL; Best SL; Gnade BE; Pearle MS; Cadeddu JA
    Urology; 2010 Nov; 76(5):1266.e10-4. PubMed ID: 21056275
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Pathogenesis of urolithiasis].
    Nihon Hinyokika Gakkai Zasshi; 1984 Nov; 75(11):1737-43. PubMed ID: 6535016
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.